Full Text View
Tabular View
No Study Results Posted
Related Studies
Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
This study has been completed.
Study NCT00030914   Information provided by National Cancer Institute (NCI)
First Received: February 14, 2002   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hot Flashes
More general conditions related to this trial
Signs and Symptoms
Interventions listed in this trial
medroxyprogesterone
venlafaxine
Additional drug interventions recognized in this trial
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Central Nervous System Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Reproductive Control Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services